The Morrison Government will invest a further $132.2 million in its response to the Aged Care Royal Commission’s recommendations on COVID-19. The Government accepted and is acting on all six recommendations from the Royal Commission into Aged Care Quality and Safety as previously announced in October 2020. The $132.2 million package includes $63.3 million for…
To mark World AIDS Day 2020 and support the ‘now more than ever’ theme, the Morrison Government will provide almost $6.2 million towards the ongoing battle against HIV, and has expanded access to Dovato® on the Pharmaceutical Benefits Scheme (PBS). Today, more than 28,000 Australians are living with HIV and it is very pleasing…
The Australian Government welcomes the COVID-19 report of the Disability Royal Commission. The effect of the COVID-19 pandemic has seen significant challenges in the way all Australians live our lives, however, the Government recognises the unique factors that need to be considered when managing the health care needs of people with disability. One of our…
There’s new hope for Australians living with a severe flesh eating ulcer, with expanded subsidised access to a key medicine on the Pharmaceutical Benefits Scheme (PBS). From 1 December, access to Rimycin 150® and 300® (rifampicin) will be expanded on the PBS for the treatment of Buruli ulcer (Mycobacterium ulcerans infection). It is expected 425…
Thousands of Australians with debilitating back and joint pain will have access to a life changing treatment option through the Pharmaceutical Benefits Scheme (PBS) which would otherwise cost tens of thousands of dollars. From December 1, access to Taltz® (ixekizumab) on the PBS will be expanded for patients with active ankylosing spondylitis. Without the PBS…
Patients living with one of Australia’s most common forms of leukaemia are set to benefit from expanded access to a breakthrough medicine through the Pharmaceutical Benefits Scheme (PBS). From 1 December, access to Venclexta® (venetoclax) will be extended in combination with obinutuzumab for the first-line treatment of patients with chronic lymphocytic leukaemia who have co-existing…
The Morrison Government is supporting six new COVID-19 research projects across four institutions, allowing researchers continue to examine the virus and our response to the pandemic. More than $4 million will be distributed from the Medical Research Future Fund (MRFF) through two grant rounds to institutions including Monash University, Deakin University and Macquarie University. These…
E&OE… Topics: Extension of telehealth; $4 million for COVID digital health delivery; European COVID cases numbers; AstraZeneca vaccine; Quarantine facilities; State borders; WA state border; Travel bubble with New Zealand; Returning Australian travellers. GREG HUNT: To have somebody who’s an outstanding medical professional in his own right as well as an outstanding medical leader, I…
E&OE… Topics: Acknowledgement of ResMed; Vaccines for COVID-19; Oxford/AstraZeneca Vaccine; Qantas; Vaccine rollout; NSW Premier; GREG HUNT: Thanks to everybody joining us here today, in particular to Brett Sandercock, the CFO of ResMed, and to Alex Hawke, who’s not only the local member, but he’s been responsible for our overseas program as Minister,…
An innovative nasal treatment to fight COVID-19, common colds and flu is being taken to the next stage of testing, thanks to the Morrison Government’s $500 million Biomedical Translation Fund. Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of…